Clinical and immunopathological evaluation of epidermolysis bullosa acquisita

Clinical and Experimental Dermatology

Volumn 36, Issue 1, 2011, Pages 12-18

  Delgado, L ^a   Aoki, V ^a   Santi, C ^a   Gabbi, T ^a   Sotto, M ^a   Maruta, C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BETAMETHASONE; COLCHICINE; CYCLOSPORIN; DAPSONE; DEXAMETHASONE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; BASEMENT MEMBRANE; BRAZIL; CHILD; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG DOSE REDUCTION; EPIDERMOLYSIS BULLOSA ACQUISITA; ESOPHAGUS DISEASE; ESOPHAGUS STENOSIS; EYE DISEASE; FEMALE; FOLLOW UP; HAND DISEASE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; INFANT; LARYNGEAL SYNECHIA; LARYNX DISORDER; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; TRICHIASIS;

ADULT; AGED; AZATHIOPRINE; BRAZIL; CHILD; CHILD, PRESCHOOL; DAPSONE; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650114213     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03845.x     Document Type: Article

References (19)

1. Elliot FI. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 1895; 13: 10-18.
2. Woodley DT, Briggaman RA, O'Keefe EJ et al. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984; 310: 1007.
3. Woodley DT, Burgeson RE, Lunstrum G et al. The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988; 81: 683-7.
4. Hallel-Hallevy D, Nadelman C, Chen M, Woodley DT. Epidermolysis bullosa acquisita. Update and review. Clin Dermatol 2001; 19: 712-18.
5. Chen M, Doostan A, Bandyopadhyay P et al. The cartilage matrix protein sub domain of type VII collagen is pathogenic for epidermolysis bullosa. AJP 2007; 170: 2009-18.
6. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007; 11: 462-81.
7. Markham CL, Darling T, Has R. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 1999; 139: 954-9.
8. Kirtschig G, Murrell DF, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita (Cochrane Review). In: The Cochrane Library, Vol. 1. Cochrane Database Syst Rev 2003; CD004056. Oxford: Update Software, 2009.
9. Murrell DF, Dick S, Ahmed AR et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-6.
10. Trigo-Guzmán Fx Conti A, Aoki V, Maruta CW et al. Epidermolysis bullosa acquisita in childhood. J Dermatol 2003; 30: 226-9.
11. Caux F, Kirtschig G. IgA Epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol 1997; 137: 270-5.
12. Callot-Mellot C, Bodemer C, Caux E et al. Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997; 133: 1122-6.
13. Mayuzumi M, Akiyama M, Nishie W et al. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol 2006; 155: 1048-52.
14. Diaz LA, Giudice GJ. End of the century overview of skin blisters. Arch Dermatol 2000; 136: 106-12.
15. Vodegel RM, Marcelus CJM, De Jong Pas HH. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 2002; 47: 919-25.
16. Suchniak JM, Diaz LA, Lin Fairley JA. IgM-mediated epidermolysis bullosa acquisita. Arch Dermatol 2002; 138: 1385-6.
17. Chan LS, Lapiere JC, Chen M et al. Bullous systemic lupus erythematosus with auto antibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol 1999; 135: 569-73.
18. Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol 2004; 22: 129-38.
19. Prussick R, Gupta AK, Assaad DM et al. Epidermolysis bullosa acquisita with features of bullous lupus erythematosus. Int J Dermatol 1994; 33: 192-5.